(Reuters) -Johnson & Johnson said on Tuesday it will resume rolling out its COVID-19 vaccine in Europe after the region's medical regulator said the benefits of the shot outweigh the risk of very rare, potentially lethal blood clots.
from Latest News https://ift.tt/3syy0Vr
No comments:
Post a Comment